Nanosphere develops, manufactures and markets a molecular diagnostics platform, the Verigene® System, which enables genomic and protein testing on a single platform. Co. is focused on the infectious disease diagnostics market. The Verigene System is comprised of a microfluidics processor, a touchscreen reader and disposable test cartridges. The reader also serves as the control station for the Verigene System and features a touchscreen interface that allows users to track samples and test cartridges, initiate and monitor test processing, analyze results and generate reports. The reader is web-enabled to allow remote access to results and reports.

NSPH — News

NSPH — Price Chart